ChristopherRobertFlowersMD

PubMed

• The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
  Fangfang Yan, Vivian Jiang, Alexa Jordan, Yuxuan Che, Yang Liu, Qingsong Cai, Yu Xue, Yijing Li, Joseph McIntosh, Zhihong Chen, Jovanny Vargas, Lei Nie, Yixin Yao, Hen...> ;Experimental Hematology & Oncology. 2024 Feb 7
• Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system i...
  Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P Iyer, Loretta J Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpi...> ;Leukemia & Lymphoma. 2024 May 1
• Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning.
  Tavolara, T., Niazi, M., Cooper, L., Gurcan, M., Feldman, A., Jaye, D., Flowers, C.> ;Diagnostic Pathology. 2024 Jan 19
• The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
  James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R C...> ;American Journal of Hematology. 2024 Mar 1
• 2 citations
  The impact of a multidisciplinary goals-of-care program on unplanned readmission rates at a comprehensive cancer center.
  Andersen, C., Wilson, K., Nortje, N., Leung, C., George, M., Flowers, C., Bruera, E., Hui, D.> ;Supportive Care in Cancer. 2023 Dec 27
• Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North Am...
  Barr, P. M., Barr, P. M., Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K Link, Me...> ;Journal of Hematology & Oncology. 2023 Dec 16
• Barriers to accessing cellular therapy for patients receiving care in community practices.
  Nze, C., Flowers, C.> ;Hematology. American Society of Hematology. Education Program. 2023 Dec 8
• Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
  Andrew P Jallouk, Naishu Kui, Ryan Sun, Jason R Westin, Raphael E Steiner, Ranjit Nair, Loretta J Nastoupil, Luis E Fayad, Ajlan Al Zaki, Misha Hawkins, Sherry Adkins,...> ;Haematologica. 2024 May 1
• Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzu...
  Matthew J Maurer, Carla Casulo, Melissa C Larson, Thomas M Habermann, Izidore S Lossos, Yucai Wang, Loretta J Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin...> ;Haematologica. 2023 Nov 30
• Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 s...
  Max J Gordon, Lei Feng, Paolo Strati, Hun Ju Lee, Fredrick B Hagemeister, Jason R Westin, Felipe Samaniego, Mario L Marques-Piubelli, Francisco Vega Vazquez, Edwin R P...> ;Cancer. 2024 Mar 15
• 22 citations
  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.
  Nigel S Key, Alok A Khorana, Nicole M Kuderer, Kari Bohlke, Agnes Y Y Lee, Juan I Arcelus, Sandra L Wong, Edward P Balaban, Christopher R Flowers, Leigh E Gates, Ajay ...> ;Journal of Clinical Oncology. 2023 Jun 1
• External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center.
  Ang Li, Giordana De Las Pozas, Clark R Andersen, Chijioke C Nze, Katy M Toale, Emily M Milner, Nathanael R Fillmore, Elizabeth Yu Chiao, Cristhiam Rojas Hernandez, Mic...> ;American Journal of Hematology. 2023 Jul 1
• 8 citations
  Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS.
  Douglas E Gladstone, Franco D'Alessio, Christopher Howard, Mi-Ae Lyu, Jason R Mock, Kevin W Gibbs, Darryl Abrams, Meixian Huang, Ke Zeng, James P Herlihy, Sergio T Cas...> ;Blood Advances. 2023 Jul 11
• 15 citations
  Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
  Jason Westin, R Eric Davis, Lei Feng, Fredrick Hagemeister, Raphael Steiner, Hun Ju Lee, Luis Fayad, Loretta Nastoupil, Sairah Ahmed, Alma Rodriguez, Michelle Fanale, ...> ;Journal of Clinical Oncology. 2023 Feb 1
• 1 citations
  BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALS.
  Ruitao Lin, Haolun Shi, Guosheng Yin, Peter F Thall, Ying Yuan, Christopher R Flowers> ;The Annals of Applied Statistics. 2022 Dec 1
• 5 citations
  A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.
  Hua-Jay J Cherng, Stefan K Alig, Yasuhiro Oki, Loretta J Nastoupil, Luis Fayad, Sattva S Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F M Craig, Charle...> ;Blood Advances. 2023 Apr 11
• 8 citations
  Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy.
  Paolo Strati, Andrew P Jallouk, Ryan Sun, Jaihee Choi, Kaberi Das, Hua-Jay Cherng, Sairah Ahmed, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Rapha...> ;Leukemia. 2022 Nov 1
• 1 citations
  Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-ba...
  Joseph Lipscomb, Jeffrey M Switchenko, Christopher R Flowers, Theresa W Gillespie, Pascale M Wortley, A Rana Bayakly, Lyn Almon, Kevin C Ward> ;Leukemia & Lymphoma. 2023 Jan 1
• 8 citations
  Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis.
  David Hui, Nico Nortje, Marina George, Kaycee Wilson, Diana L Urbauer, Caitlin A Lenz, Susannah Kish Wallace, Clark R Andersen, Tito Mendoza, Sajid Haque, Sairah Ahmed...> ;Journal of Clinical Oncology. 2023 Jan 20
• 19 citations
  Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
  Guangchun Han, Qing Deng, Mario L Marques-Piubelli, Enyu Dai, Minghao Dang, Man Chun John Ma, Xubin Li, Haopeng Yang, Jared Henderson, Olga Kudryashova, Mark Meerson, ...> ;Blood Cancer Discovery. 2022 Sep 6
• 1 citations
  Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.
  Jason T Romancik, Zhengjia Chen, Pamela B Allen, Edmund K Waller, Kelly Valla, Amanda Colbert, Cecilia Rosand, Alexandra F Palmer, Christopher R Flowers, Jonathon B Cohen> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Dec 1
• 11 citations
  Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
  Dai Chihara, Ruitao Lin, Christopher R Flowers, Shanda R Finnigan, Lisa M Cordes, Yoko Fukuda, Erich P Huang, Larry V Rubinstein, Loretta J Nastoupil, S Percy Ivy, Jam...> ;Lancet. 2022 Aug 13
• Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis.
  Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R Flowers, Brian Link, Jonathan W Friedberg, Jonathon B Cohen, Brad Kahl, Izidore S Lossos, Loretta Nastoupil, Ma...> ;Blood Advances. 2022 Aug 9
• 18 citations
  Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
  Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang, Cao Cuong Le, Qing Deng, Luis Fayad, Nathan H Fowler, Simrit Parmar, Raphael Steiner, Fredrick Ha...> ;Blood. 2022 Aug 4
• Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical T...
  Jesse G Dixon, Çağlar Çağlayan, Dai Chihara, Tina Nielsen, Natalie Dimier, Jamie Zheng, Anna K Wall, Gilles Salles, Franck Morschhauser, Robert Marcus, Michael Herold,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Nov 1
• Join now to see all

Journal Articles

• Incidence and Outcomes of Lymphoid Malignancies in Adolescent and Young Adult Patients in the United States  
  Sharon Castellino, Frank G Keller, Christopher R Flowers, British Journal of Haematology

Abstracts/Posters

• Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i...
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Promoting Minorities in Hematology Presentations and Reception 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Meeting Tips: Giving a Scientific Presentation, Being a Good Discussant and Asking a Question in the Aisle 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Polatuzumab Vedotin (Pola) Plus Bendamustine (B) with Rituximab (R) or Obinutuzumab (G) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Updated Res... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-Κb Pathway 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• DLBCL Genomics 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all